The MRC Clinical Trials Unit (CTU) is a centre of excellence for clinical trials, meta-analyses and epidemiological studies

We are committed to strengthening and expanding the evidence base for healthcare nationally and internationally.

The CTU also develops methodology to improve the design, conduct and analysis of clinical studies, and hosts one of the MRC’s eight regional Hubs for Trials Methodology Research.

The MRC CTU is a UKCRC registered trials unit.

click on the right Read more about the Unit 

Latest News

95 years of research for the MRC

The MRC Clinical Trials Unit at UCL (MRC CTU) celebrated the work of three of its most eminent scientists with a one-day seminar on 8th April. Professors Abdel Babiker, Andrew Nunn and Patrick Royston have between them been funded by the MRC for a total of 95 years, with Andrew Nunn out in the lead with a staggering 48 years. The day was made up of scientific presentations from collaborators with whom the three have worked closely.

Purple Right Arrow Read full report

COIN-B shows cetuximab can be safely added to two intermittent chemotherapy strategies for advanced colorectal cancer

The results of the COIN-B randomised phase II trial for the treatment of advanced colorectal cancer have been published. COIN-B was looking to see if taking cetuximab either continuously or with planned breaks, alongside intermittent chemotherapy (chemotherapy with planned breaks), was safe and active against the disease. The trial found that both strategies were safe, and patients did well.

Purple Right Arrow Read full report

KONCERT results do not support the routine use of once-daily Kaletra dosing for children with HIV

The results of a trial looking at whether taking the drug Kaletra once a day was as good as taking it twice a day for children with HIV were presented at the Conference on Retroviruses and Opportunistic Infections last week. The KONCERT results do not support the routine use of once-daily Kaletra dosing for children with HIV.

Purple Right Arrow Read full report

Other news

prarrow More news and press releases

Our Research Areas

Browser does not support script.